Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a phase 3, non-inferiority, randomised open-label clinical trial

INTRODUCTION: Malaria infection during pregnancy increases the risk of low birth weight and infant mortality and should be prevented and treated. Artemisinin-based combination treatments are generally well tolerated, safe and effective; the most used being artemether-lumefantrine (AL) and dihydroart...

Descripción completa

Detalles Bibliográficos
Autores principales: Djimde, Moussa, Tshiongo, Japhet Kabalu, Muhindo, Hypolite Mavoko, Tinto, Halidou, Sevene, Esperanca, Traore, Maminata, Vala, Anifa, Macuacua, Salesio, Kabore, Berenger, Dabira, Edgard Diniba, Erhart, Annette, Diakite, Hamadoun, Keita, Mohamed, Piqueras, Mireia, González, Raquel, Menendez, Clara, Dorlo, Thomas PC, Sagara, Issaka, Mens, Petra, Schallig, Henk, D'Alessandro, Umberto, Kayentao, Kassoum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565244/
https://www.ncbi.nlm.nih.gov/pubmed/37813539
http://dx.doi.org/10.1136/bmjopen-2022-065295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565244/
https://www.ncbi.nlm.nih.gov/pubmed/37813539
http://dx.doi.org/10.1136/bmjopen-2022-065295

Ejemplares similares